Inhibition of acyl-coenzyme A: Cholesterol acyltransferase stimulates cholesterol efflux from macrophages and stimulates farnesoid X receptor in hepatocytes

Experimental and Molecular Medicine

Volumn 40, Issue 4, 2008, Pages 407-417

  An, Sojin ^a,d   Jang, Young Soon ^b   Park, Ji Seon ^a   Kwon, Byoung Mog ^c   Paik, Young Ki ^d   Jeong, Tae Sook ^a  

^a National Research Laboratory of Lipid Metabolism and Atherosclerosis   (South Korea)

^b Therapeutic Antibody Research Center   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d Yonsei University   (South Korea)

Author keywords

Bile; Cholesterol; Cytochrome P 450 enzyme system; Farnesoid X activated receptor; Oleoyl anilide; Sterol O acyltransferase

Indexed keywords

ACYL COENZYME A; ANILIDE; CHOLESTEROL; CHOLESTEROL 27 HYDROXYLASE; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; ENZYME; FARNESOID X RECEPTOR; OLEIC ACID; OXYSTEROL 7ALPHA HYDROXYLASE; UNCLASSIFIED DRUG;

ARTICLE; CHOLESTEROL METABOLISM; CYTOTOXICITY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID STORAGE; LIVER CELL; MACROPHAGE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION;

EID: 51949108672     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2008.40.4.407     Document Type: Article

References (46)

1. Avdeef A. The rise of PAMPA. Expert Opin Drug Metab Toxicol 2005;1:325-42
2. Axelson M, Sjövall J. Potential bile acid precursors in plasma-possible indicators of biosynthetic pathways to cholic and chenodeoxycholicacids in man. J Steroid Biochem 1990;36: 631-40
3. Basu SK, Goldstein JL, Anderson RGW, Brown MS. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci USA 1976;73:3178-82
4. Batetta B, Mulas MF, Sanna F, Putzolu M, Bonatesta RR, Gasperi-Campani A, Roncuzzi L, Baiocchi D, Dessi S. Role of cholesterol ester pathway in the control of cell cycle in human aortic smooth muscle cells. FASEBJ 2003;17:746-8
5. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-7
6. Buhman KF, Accad M, Farese RV. Mammalian acyl-CoA: cholesterol acyltransferases. Biochim Biophys Acta 2000; 1529:142-54
7. Cheon H, Woo YS, Lee JY, Kim HS, Kim HJ, Cho S, Won NH, Sohn J. Signaling pathway for 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced TNF-alpha production in differentiated THP-1 human macrophages. Exp Mol Med 2007;39:524-34
8. Chiang JY, Kimmel R, Weinberger C, Stroup D. FarnesoidX receptor responds to bile acids and represses cholesterol 7-hydroxylase gene (CYP7A1) transcription. J Biol Chem 2000;275:10918-24
9. Chiang JY, Kimmel R, Stroup D. Regulation of cholesterol 7a-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRoc). Gene 2001;262:257-65
10. Cho KH, An S, Lee WS, Paik YK, Kim YK, Jeong TS. Mass-production of human ACAT-1 and ACAT-2 to screen isoform-specific inhibitor: A different substrate specificity and inhibitory regulation. Biochem Biophys Res Commun 2003; 309:864-72
11. Cignarella A, Engel T, von Eckardstein A, Kratz M, Lorkowski S, Lueken A, Assmann G, Cullen P. Pharmacological regulation of cholesterol efflux in human monocyte-derived macrophages in the absence of exogenous cholesterol acceptors. Atherosclerosis 2005;179:229-36
12. Claudel T, Sturm E, Duez H, Torra IP, Sirvent A, Kosykh V, Fruchart JC, Dallongeville J, Hum DW, Kuipers F, Staels B. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-l transcription via a negative FXR response element. J Clin Invest 2002;109:961-71
13. Feng B, Tabas I. ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity. J Biol Chem 2002; 277:43271-80
14. Fu X, Menke JG, Chen Y, Zhou G, MacNaul KL, Wright SD, Sparrow CP, Lund EG. 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J Biol Chem 2001;42:38378-87
15. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979; 76:333-7
16. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000;6: 517-26
17. Hatch FT, Lees RS. Practical methods for plasma lipoprotein analysis. Adv Lipid Res 1968;6:1-68
18. Kansy M, Senner F, Gubernator K. Physicochemical high throughput screening: parallel artificial membrane permeability assay in the description of passive absorption processes. J Med Chem 1998;41; 1007-10
19. Kliewer SA, Goodwin B, Willson TM. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 2002;23:687-702
20. Labonte ED, Li Q, Agellon LB. Expression of cholesterol 7alpha-hydroxylase restores bile acid synthesis in McArdle RH7777 cells. Arch Biochem Biophys 2000;381:273-7
21. Li YC, Wang DP, Chiang JY. Regulation of cholesterol 7 alpha-hydroxylase in the liver. Cloning, sequencing, and regulation of cholesterol 7 alpha-hydroxylase mRNA. J Biol Chem 1990;265:12012-9
22. Liu ML, Hong ST. Early phase of amyloid beta42-induced cytotoxicity in neuronal cells is associated with vacuole formation and enhancement of exocytosis. Exp Mol Med 2005;37:559-66
23. Mak PA, Kast-Woelbern HR, Anisfeld AM, Edwards PA. Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors. J Lipid Res 2002;43:2037-41
24. Miyake JH, Duong-Polk XT, Taylor JM, Du EZ, Castellani LW, Lusis AJ, Davis RA. Transgenic expression of cholesterol-7a-hydroxylase prevents atherosclerosis in C57BL/6J mice. Arterioscler Thromb Vase Biol 2002;22:121-6
25. Moore GL, Davis RA. Expression of cholesterol-7alpha-hydroxylase in murine macrophages prevents cholesterol loading by acetyl-LDL. J Lipid Res 2002;43:629-35
26. Nicholls SJ, Sipahi I, Schoenhagen P, Wisniewski L, Churchill T, Crowe T, Goormastic M, Wolski K, Tuzcu EM, Nissen SE; ACTIVATE Investigators. Intravascular ultrasound assessment of novel antiatherosclerotic therapies: Rationale and design of the acyl- CoA:cholesterol acyl-transferase intravascular atherosclerosis treatment evaluation (ACTIVATE) study. Am Heart J 2006;152:67-74
27. Nishimaki-Mogami T, Une M, Fujino T, Sato Y, Tamehiro N, Kawahara Y, Shudo K, Inoue K. Identification of intermediates in the bile acid synthetic pathway as ligands for the farnesoid X receptor. J Lipid Res 2004;45:1538-45
28. Post SM, Zoeteweij JP, Bos MH, de Wit EC, Havinga R, Kuipers F, Princen HM. Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat. Hepatology 1999;30: 491-500
29. Rodriguez A, Bachorik PS, Wee SB. Novel effects of the acyl-coenzyme A:Cholesterol acyltransferase inhibitor 58-035 on foam cell development in primary human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 1999;19:2199-206
30. Rodriguez A, Usher DC. Anti-atherogenic effects of the acyl-CoA:cholesterol acyltransferase inhibitor, avasimibe (CI-1011), in cultured primary human macrophages. Atherosclerosis 2002; 161:45-54
31. Rong JX, Kusunoki J, Oelkers P, Sturley SL, Fisher EA. Acyl-Coenzyme A (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation. Arterioscler Thromb Vasc Biol 2005;25:122-7
32. Roth BD, Blankley CJ, Hoefle ML, Holmes A, Roark WH, Trivedi BK, Essenburg AD, Kieft KA, Krause BR, Stanfield RL. Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Identification and structure-activity relationships of a novel series of fatty acid anilide hypocholesterolemic agents. J Med Chem 1992;35:1609-17
33. Rudel L, Deckelman C, Wilson M, Scobey M, Anderson R. Dietarycholesterol and down-regulation of cholesterol 7α-hydroxylase and cholesterol absorption in African green monkeys. J Clin Invest 1994;93:2463-72
34. Russell, DW. Nuclear orphan receptors control cholesterol catabolism. Cell 1999;97:539-42
35. 14C-cholesterol excreted in bile and feces. Proc Soc Exp Biol Med 1952;81:720-4
36. Stedman C, Liddle C, Coulter S, Sonoda J, Alvarez JG, Evans RM, Downes M. Benefit of farnesoid X receptor inhibition in obstructive cholestasis. Proc Natl Acad Sci USA 2006;103:11323-8
37. Tabas I, Boykow GC, Tall AR. Foam cell-forming J774 macrophages have markedly elevated acyl coenzyme A:cholesterol acyl transferase activity compared with mouse peritoneal macrophages in the presence of low density lipoprotein (LDL) despite similar LDL receptor activity. J Clin Invest 1987;79:418-26
38. Tardif JC, GregoireJ, L'Allier PL, Anderson TJ, Bertrand O, Reeves F, Title LM, Alfonso F, Schampaert E, Hassan A, McLain R, Pressler ML, Ibrahim R, Lesperance J, Blue J, Heinonen T, Rodes-Cabau J. Avasimibe and Progression of Lesions on UltraSound (A-PLUS) Investigators. Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 2004;110:3372-77
39. Urizar NL, Liverman AB, Dodds DT, Silva FV, Ordentlich P, Yan Y, Gonzalez FJ, Heyman RA, Mangelsdorf DJ, Moore DD. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 2002;296:1703-6
40. Urizar NL, Moore DD. GUGULIPID: a natural cholesterol-lowering agent. Annu Rev Nutr 2003;23:303-13
41. Von Eckardstein A, Nofer JR, Assmann G. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 2001;21:13-27
42. Warner GJ, Stoudt G, Bamberger M, Johnson WJ, Rothblat GH. Cell toxicity induced by inhibition of acyl coenzyme A: cholesterol acyltransferaseand accumulation of unesterified cholesterol. J Biol Chem 1995;270:5772-78
43. Wu J, Xia C, Meier J, Li S, Hu X, Lala DS. The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor. Mol Endocrinol 2002;16:1590-7
44. Xu G, Li H, Pan LX, Shang Q, Honda A, Ananthanarayanan M, Erickson SK, Shneider BL, Shefer S, Bollineni J, Forman BM, Matsuzaki Y, Suchy FJ, Tint GS, Salen G. FXR-mediated down-regulation of CYP7A1 dominates LXRα in long-term cholesterol-fed NZW rabbits. J Lipid Res 2003;44:1956-62
45. Zhang J, Larsson O, Sjövall J. 7α-Hydroxylation of 25-hydroxycholesterol and 27-hydroxycholesterol in human fibroblasts. Biochim Biophys Acta 1995;1256:353-9
46. Zhang Y, Wang X, Vales C, Lee FY, Lee H, Lusis AJ, Edwards PA. FXR Deficiency Causes Reduced Atherosclerosis in Ldlr-/- Mice. Arterioscler Thromb Vasc Biol 2006;26:2316-21